mk2 sirna nucleotide Search Results


mk2 sirna nucleotide  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology mk2 sirna nucleotide
Figure 4 Phosphorylation by <t>MK2</t> attenuates the action of stimulatory phosphorylation by PKA
Mk2 Sirna Nucleotide, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mk2 sirna nucleotide/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
mk2 sirna nucleotide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Figure 4 Phosphorylation by MK2 attenuates the action of stimulatory phosphorylation by PKA

Journal: Biochemical Journal

Article Title: Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation

doi: 10.1042/bj20101184

Figure Lengend Snippet: Figure 4 Phosphorylation by MK2 attenuates the action of stimulatory phosphorylation by PKA

Article Snippet: COS1 cells were transfected using either Polyfect® reagent (Qiagen) or DEAE-dextran (Sigma–Aldrich) as described previously [10,11]. siRNAs The PolyFect® method of mammalian cell transfection (Qiagen) was used for the transfection of COS1 cells with an MK2 siRNA nucleotide from Santa Cruz Biotechnology, as reported previously [12].

Techniques: Phospho-proteomics

Figure 5 MK2 phosphorylation of PDE4A5 alters its ability to regulate intracellular cAMP concentrations

Journal: Biochemical Journal

Article Title: Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation

doi: 10.1042/bj20101184

Figure Lengend Snippet: Figure 5 MK2 phosphorylation of PDE4A5 alters its ability to regulate intracellular cAMP concentrations

Article Snippet: COS1 cells were transfected using either Polyfect® reagent (Qiagen) or DEAE-dextran (Sigma–Aldrich) as described previously [10,11]. siRNAs The PolyFect® method of mammalian cell transfection (Qiagen) was used for the transfection of COS1 cells with an MK2 siRNA nucleotide from Santa Cruz Biotechnology, as reported previously [12].

Techniques: Phospho-proteomics

Figure 6 MK2 phosphorylation of PDE4A5 attenuates its ability to be reversibly recruited into intracellular aggregates by chronic rolipram treatment

Journal: Biochemical Journal

Article Title: Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation

doi: 10.1042/bj20101184

Figure Lengend Snippet: Figure 6 MK2 phosphorylation of PDE4A5 attenuates its ability to be reversibly recruited into intracellular aggregates by chronic rolipram treatment

Article Snippet: COS1 cells were transfected using either Polyfect® reagent (Qiagen) or DEAE-dextran (Sigma–Aldrich) as described previously [10,11]. siRNAs The PolyFect® method of mammalian cell transfection (Qiagen) was used for the transfection of COS1 cells with an MK2 siRNA nucleotide from Santa Cruz Biotechnology, as reported previously [12].

Techniques: Phospho-proteomics

Figure 7 MK2 phosphorylation of PDE4A5 and its ability to be sequestered by partner proteins

Journal: Biochemical Journal

Article Title: Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation

doi: 10.1042/bj20101184

Figure Lengend Snippet: Figure 7 MK2 phosphorylation of PDE4A5 and its ability to be sequestered by partner proteins

Article Snippet: COS1 cells were transfected using either Polyfect® reagent (Qiagen) or DEAE-dextran (Sigma–Aldrich) as described previously [10,11]. siRNAs The PolyFect® method of mammalian cell transfection (Qiagen) was used for the transfection of COS1 cells with an MK2 siRNA nucleotide from Santa Cruz Biotechnology, as reported previously [12].

Techniques: Phospho-proteomics